Replay available

Vanda Pharmaceuticals Inc. (VNDA) Q4 2025 Earnings Call

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Q4 2025 earnings conference call, held 2026-02-11. Replay captured from the company's public earnings webcast.

Wed, February 11, 2026 at 4:30 PMendedReplay
Vanda Pharmaceuticals Inc. (VNDA) Q4 2025 Earnings Call

Hosted by

Featured presenters

Kevin Morant

Chief Financial Officer

Dr. Mahalis Polymeropoulos

President, Chief Executive Officer and Chairman of the Board

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vanda Pharmaceuticals Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.375 Thank you for standing by. My name is Jordan, and I'll be your conference operator today. 00:00:04.375 -- 00:00:10.241 At this time, I'd like to welcome everyone to the Q4 2025 Vanda Pharmaceuticals, 00:00:10.241 -- 00:00:15.005 Inc. earnings conference call. All lines have been placed on mute to prevent any background 00:00:15.005 -- 00:00:19.269 noise. After the speaker's remarks, there will be a question and answer session. 00:00:19.269 -- 00:00:23.493 If you would like to ask a question during this time, simply press star followed by the 00:00:23.493 -- 00:00:27.777 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:27.777 -- 00:00:32.842 star one again. Thank you. I'd now like to turn the call over to Kevin Morant, 00:00:32.842 -- 00:00:36.968 Vanda's Chief Financial Officer. Please go ahead. 00:00:36.968 -- 00:00:41.796 Thank you, Jordan. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceutical's 00:00:41.796 -- 00:00:45.381 fourth quarter and full year 2025 performance. 00:00:45.381 -- 00:00:50.529 Our fourth quarter and full year 2025 results were released this afternoon and are available 00:00:50.529 -- 00:00:56.095 on the SEC's EDGAR system and on our website, www.vandapharma.com. 00:00:57.271 -- 00:01:01.435 In addition, we are providing live and archived versions of this conference call on our 00:01:01.435 -- 00:01:04.418 website. Joining me on today's call is Dr. 00:01:04.418 -- 00:01:09.323 Mahalis Polymeropoulos, our President, Chief Executive Officer, and Chairman of the Board, 00:01:09.323 -- 00:01:12.046 and Tim Williams, our General Counsel. 00:01:12.046 -- 00:01:16.351 Following my introductory remarks, Mahalis will update you on our ongoing activiti...